Journals / Turkish Journal of Pediatrics / 2021 / Cilt: 63 - Sayı: 3

Enthesitis: an obscured extraintestinal manifestation in pediatric inflammatory bowel disease

Pages
345–354
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Future studies with more extensive cohorts are needed to evaluate enthesial involvement both with physical examination and US in order to predict the long-term outcomes of the enthesitis on children with IBD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Enthesitis is an extra-intestinal manifestation of inflammatory bowel disease (IBD) which often remains underdiagnosed in children.
📊
Key Findings & Data:Methods. 31 children, 7 -18 years of age, diagnosed with IBD were recruited for a cross-sectional study.
💡
Conclusion & Impact:Future studies with more extensive cohorts are needed to evaluate enthesial involvement both with physical examination and US in order to predict the long-term outcomes of the enthesitis on children with IBD.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background. Enthesitis is an extra-intestinal manifestation of inflammatory bowel disease (IBD) which often remains underdiagnosed in children. We aimed to evaluate the frequency of enthesitis in pediatric IBD patients using physical examination and ultrasound (US) assessment as the reference standard. Methods. 31 children, 7 -18 years of age, diagnosed with IBD were recruited for a cross-sectional study. All subjects completed a study questionnaire and underwent both physical and US examination for the presence of the enthesitis. Results. Of 31 subjects (17girls; median age 14(6) years) enrolled, 17 (55%) had ulcerative colitis, 11 (35%) had Crohn’s disease, and 3 (10%) had indeterminate colitis. The median time from IBD diagnosis was 1.2 years. At least one enthesitis (range 1–4) was identified in 14 (45%) patients of whom nine had more than one enthesitis with symmetric involvement in eight. The quadriceps femoris insertion at the superior portion of the patella was the frequently involved site (32%, 9 of 28 sites), followed by patellar ligament insertion at tibial tuberositas. The presence of enthesitis was associated with a higher intensity of the musculoskeletal pain (p=0.018), but physical activity remained unaffected (p=0.056). Conclusions. Enthesitis is a common underestimated extra-intestinal manifestation of IBD that may impact the musculoskeletal health of children. Future studies with more extensive cohorts are needed to evaluate enthesial involvement both with physical examination and US in order to predict the long-term outcomes of the enthesitis on children with IBD.

🔖

Cite This Article

SÖZERİ, B., GERENLİ, N. (2022). Enthesitis: an obscured extraintestinal manifestation in pediatric inflammatory bowel disease. Turkish Journal of Pediatrics, Cilt: 63 - Sayı: 3, 345–354. https://ajindex.com/articles/613071

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Mamula P, Markowitz JE, Baldassano RN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am 2003; 32: 967-995
  2. Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci 1999; 44: 1-13
  3. Watad A, Cuthbert RJ, Amital H, McGonagle D. Enthesitis: much more than focal insertion point inflammation. Curr Rheumatol Rep 2018; 20: 41
  4. Chauvin NA, Ho-Fung V, Jaramillo D, Edgar JC, Weiss PF. Ultrasound of the joints and entheses in healthy children. Pediatr Radiol 2015; 45: 1344-1354
  5. Jousse-Joulin S, Breton S, Cangemi C, et al. Ultrasonography for detecting enthesitis in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2011; 63: 849-855
  6. Shenoy S, Aggarwal A. Sonologic enthesitis in children with enthesitis-related arthritis. Clin Exp Rheumatol 2016; 34: 143-147
  7. Sheth T, Pitchumoni CS, Das KM. Musculoskeletal manifestations in inflammatory bowel disease: a revisit in search of immunopathophysiological mechanisms. J Clin Gastroenterol 2014; 48: 308-317
  8. Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T. Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment. World J Gastroenterol 2019; 25: 2162-2176
  9. Conti F, Borrelli O, Anania C, et al. Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig Liver Dis 2005; 37: 761-767
  10. Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells. Nat Med 2012; 18: 1069-1076
  11. Kalinkovich A, Livshits G. A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies. Semin Arthritis Rheum 2019; 49: 474- 484
  12. Kaeley GS, Kaler JK. Peripheral enthesitis in spondyloarthritis: lessons from targeted treatments. Drugs 2020; 80: 1419-1441
  13. Dotson J, Crandall W, Bout-Tabaku S. Exploring the differential diagnosis of joint complaints in pediatric patients with inflammatory bowel disease. Curr Gastroenterol Rep 2011; 13: 271-278
  14. Jang HJ, Kang B, Choe BH. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl Pediatr 2019; 8: 4-15
  15. Rodríguez-Reyna TS, Martínez-Reyes C, YamamotoFurusho JK. Rheumatic manifestations of inflammatory bowel disease. World J Gastroenterol 2009;